Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Heliyon|March 15, 2024
Designing a conjugate vaccine targeting Klebsiella pneumoniae ST258 and ST11Min Li, Mingkai Yu, Yigang Yuan, et al.Clinical Epigenetics|February 5, 2025
miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world settingYilan Xu, Danyang Li, Na Wang, et al.Clinical Epigenetics|October 29, 2025
NSUN2 promotes leukemogenesis by ferritin heavy chain 1-mediated anti-ferroptosis and enhancing global protein synthesis in an m5C-dependent manner in B-acute lymphoblastic leukemiaYigang Yuan, Min Li, Xuanyu Yu, et al.Clinical Epigenetics|March 26, 2024
Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclaxDanyang Li, Yigang Yuan, Chen Meng, et al.Theranostics|January 3, 2023
DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclaxSisi Ye, Fang Xiong, Xiaofei He, et al.Experimental Hematology & Oncology|February 20, 2024
Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemiaShuya Feng, Yigang Yuan, Zihan Lin, et al.Haematologica|March 12, 2026
NSUN2-FOSB reciprocity facilitates leukemogenesis in an m5C-dependent manner by increasing BCL2L1 expressionBin Zhou, Yigang Yuan, Yue Cai, et al.Pageof 1